New Jersey

True Influence Announces a No Layoff Pledge, Challenging Companies to Stop the Downsizing in the Marketing and Advertising Community During the COVID-19 Crisis

PRINCETON, , March 30, 2020 /PRNewswire/ -- In an effort to support its employees, as well as the marketing and advertising community,  True Influence® has pledged to have no layoffs for 90…
Continue Reading »
New Jersey

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate…
Continue Reading »
New Jersey

PBF Energy Announces Planned $530 million Hydrogen Plant Sales, Reduction in 2020 Cash Outlays by Over $500 million through Lowered Capital and Operating Expenses, Dividend Suspension and Other Deferrals

PARSIPPANY, , March 30, 2020 /PRNewswire/ -- PBF Energy Inc. (NYSE: PBF) today announced a number of decisive steps taken as part of a strategic plan for PBF to navigate current…
Continue Reading »
New Jersey

Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization

RARITAN, , March 28, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating…
Continue Reading »